BFM
AGN

Boothbay Fund Management’s Allergan plc AGN Stock Holding History

Boothbay Fund Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$3.35M – 976
2019
Q2 		$3.35M Sell
200
-299
-60% -$41.4K 0.3% 66
2019
Q1 		$7.31M Buy
+499
New +$72.3K 0.71% 21
2018
Q4 		– Sell
-289
Closed -$5.5M – 1005
2018
Q3 		$5.5M Buy
289
+246
+572% +$45.2K 0.54% 36
2018
Q2 		$717K Buy
+43
New +$6.9K 0.06% 247

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Boothbay Fund Management's AGN Position: Q2 2020 in Review

Boothbay Fund Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 261,949 shares — an estimated $46.4M sold.

Boothbay Fund Management first reported a position in AGN in Q1 2016 and held it in 10 quarters. The position peaked at $46.4M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Boothbay Fund Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 261,949 Allergan plc shares in Q2 2020, an estimated $46.4M.
  • Boothbay Fund Management first reported a position in Allergan plc in Q1 2016 and held it in 10 quarters.
  • Boothbay Fund Management's Allergan plc position peaked at $46.4M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.